Omega Diagnostics Partner Requests Independent Covid Test Evaluation
June 15 2021 - 07:09AM
Dow Jones News
By Joe Hoppe
Omega Diagnostics Group PLC said Tuesday that technology partner
Mologic Ltd. has requested an independent evaluation of its
coronavirus test, but that this won't have implications for its
U.K. government manufacturing contract.
The London-listed medical-diagnostics company said Mologic, its
partner in developing a rapid coronavirus test, has requested
research lab Porton Down evaluate its test with an independent
party observing. The move comes in response to media speculation
that Mologic's tests have been blocked by the U.K. government.
The company said this won't affect its contract with the
Department of Health and Social Care, or DHSC. Under that contract
it will use equipment loaned by the U.K. government to manufacture
whichever test the DHSC approves.
Shares at 1039 GMT were down 4.5 pence, or 6.5%, at 65.0 pence.
Shares fell as much as 14% earlier in the session.
Write to Joe Hoppe at joseph.hoppe@wsj.com
(END) Dow Jones Newswires
June 15, 2021 06:59 ET (10:59 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
Omega Diagnostics (LSE:ODX)
Historical Stock Chart
From Feb 2024 to Mar 2024
Omega Diagnostics (LSE:ODX)
Historical Stock Chart
From Mar 2023 to Mar 2024